• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌手术治疗和时机的变化:决定因素和差异。

Variations in breast cancer surgical treatment and timing: determinants and disparities.

机构信息

IBM Watson Health, 75 Binney Street, Cambridge, MA, 02142, USA.

RxEconomics LLC, Hunt Valley, MD, USA.

出版信息

Breast Cancer Res Treat. 2021 Jul;188(1):259-272. doi: 10.1007/s10549-021-06155-1. Epub 2021 Mar 10.

DOI:10.1007/s10549-021-06155-1
PMID:33689057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8233284/
Abstract

PURPOSE

To describe clinical and non-clinical factors associated with receipt of breast conserving surgery (BCS) versus mastectomy and time to surgical intervention.

METHODS

Cross-sectional retrospective study of January 1, 2012 through March 31, 2018 data from the IBM MarketScan Commercial Claims and Encounter and Medicare Supplemental Databases. Area Health Resource Files provided non-clinical characteristics and sociodemographic data. Eligibility: Female sex, claim(s) with ICD-9-CM or ICD-10-CM diagnosis of non-metastatic invasive breast cancer, > 6 months of continuous insurance pre- and post-diagnosis, evidence of BCS or mastectomy following initial ICD9/10 code diagnosis. Logistic and quantile multivariable regression models assessed the association between clinical and non-clinical factors and the outcome of BCS and time to surgery, respectively.

RESULTS

A total of 53,060 women were included in the study. Compared to mastectomy, BCS was significantly associated with older age (ORs: 1.54 to 2.99, 95% CIs 1.45 to 3.38; ps < .0001) and higher community density of medical genetics (OR: 5.88, 95% CIs 1.38 to 25.00; p = 0.02) or obstetrics and gynecology (OR: 1.13, 95% CI 1.02 to 1.25; p = .02) physicians. Shorter time-to-BCS was associated with living in the South (-2.96, 95% CI -4.39 to -1.33; p < .0001). Longer time-to-BCS was associated with residence in more urban (4.18, 95% CI 0.08 to 8.29; p = 0. 05), educated (9.02, 95% CI 0.13 to 17.91; p = 0.05), or plastic-surgeon-dense (4.62, 95% CI 0.50 to 8.73; p = 0.03) communities.

CONCLUSIONS

Clinical and non-clinical factors are associated with adoption of BCS and time to treatment, suggesting opportunities to ensure equitable and timely care.

摘要

目的

描述与保乳手术(BCS)与乳房切除术相关的临床和非临床因素,以及手术干预的时间。

方法

这是一项回顾性的队列研究,纳入了 2012 年 1 月 1 日至 2018 年 3 月 31 日期间来自 IBM MarketScan 商业索赔和就诊数据库以及医疗保险补充数据库的数据。区域卫生资源文件提供了非临床特征和社会人口统计学数据。入选标准:女性,索赔中包含 ICD-9-CM 或 ICD-10-CM 诊断为非转移性浸润性乳腺癌的诊断,在诊断前和诊断后有至少 6 个月的连续保险,在初始 ICD9/10 代码诊断后有 BCS 或乳房切除术的证据。逻辑回归和分位数多变量回归模型分别评估了临床和非临床因素与 BCS 结局和手术时间之间的关系。

结果

本研究共纳入了 53060 名女性。与乳房切除术相比,BCS 与年龄较大(ORs:1.54 至 2.99,95%CI 1.45 至 3.38;p<0.0001)和更高的社区医疗遗传学(OR:5.88,95%CI 1.38 至 25.00;p=0.02)或妇产科(OR:1.13,95%CI 1.02 至 1.25;p=0.02)医生密度显著相关。BCS 时间较短与居住在南部(-2.96,95%CI -4.39 至 -1.33;p<0.0001)有关。BCS 时间较长与居住在更城市化(4.18,95%CI 0.08 至 8.29;p=0.05)、教育程度更高(9.02,95%CI 0.13 至 17.91;p=0.05)或整形外科医生密度较高(4.62,95%CI 0.50 至 8.73;p=0.03)的社区有关。

结论

临床和非临床因素与 BCS 的采用和治疗时间有关,这表明有机会确保公平和及时的护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/8233284/a65df167acd3/10549_2021_6155_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/8233284/a65df167acd3/10549_2021_6155_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/8233284/a65df167acd3/10549_2021_6155_Fig1_HTML.jpg

相似文献

1
Variations in breast cancer surgical treatment and timing: determinants and disparities.乳腺癌手术治疗和时机的变化:决定因素和差异。
Breast Cancer Res Treat. 2021 Jul;188(1):259-272. doi: 10.1007/s10549-021-06155-1. Epub 2021 Mar 10.
2
Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery.保乳手术后再次切除术和改行乳房切除术的比率及相关医疗保健费用的当代分析。
Ann Surg Oncol. 2024 Jun;31(6):3649-3660. doi: 10.1245/s10434-024-14902-z. Epub 2024 Feb 6.
3
Non-doctoral factors influencing the surgical choice of Chinese patients with breast cancer who were eligible for breast-conserving surgery.影响有保乳手术适应证的中国乳腺癌患者选择手术方式的非医学因素。
World J Surg Oncol. 2019 Nov 11;17(1):189. doi: 10.1186/s12957-019-1723-4.
4
Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer: A Population-Based Study.老年早期乳腺癌女性初始局部治疗的差异:一项基于人群的研究。
J Womens Health (Larchmt). 2017 Jul;26(7):735-744. doi: 10.1089/jwh.2015.5639. Epub 2017 Feb 7.
5
Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.老年浸润性乳腺癌患者的保乳手术:美国目前的治疗模式
J Am Coll Surg. 2009 Oct;209(4):425-433.e2. doi: 10.1016/j.jamcollsurg.2009.06.363. Epub 2009 Aug 20.
6
Medicare breast surgery fees and treatment received by older women with localized breast cancer.老年局限性乳腺癌女性患者的医疗保险乳房手术费用及接受的治疗
Health Serv Res. 2003 Apr;38(2):553-73. doi: 10.1111/1475-6773.00133.
7
The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.医院和外科医生因素对导管原位癌腋窝淋巴结评估流行率的影响。
JAMA Oncol. 2015 Jun;1(3):323-32. doi: 10.1001/jamaoncol.2015.0389.
8
Association of Race, Ethnicity, Insurance, and Language and Rate of Breast-Conserving Therapy Among Women With Nonmetastatic Breast Cancer at an Urban, Safety-Net Hospital.非转移性乳腺癌女性的种族、民族、保险、语言和保乳治疗率与城市保障医院的关联。
J Surg Res. 2023 Nov;291:403-413. doi: 10.1016/j.jss.2023.06.009. Epub 2023 Jul 28.
9
Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa.南非索韦托地区局部乳腺癌女性患者保乳手术与全乳切除术的对比研究
PLoS One. 2017 Aug 10;12(8):e0182125. doi: 10.1371/journal.pone.0182125. eCollection 2017.
10
The use of breast conserving surgery: linking insurance claims with tumor registry data.保乳手术的应用:将保险理赔与肿瘤登记数据相联系。
BMC Cancer. 2002;2:3. doi: 10.1186/1471-2407-2-3. Epub 2002 Mar 5.

引用本文的文献

1
Ethnoracial disparities in breast cancer treatment time and survival: a systematic review with a DAG-based causal model.乳腺癌治疗时间和生存率方面的种族差异:基于有向无环图因果模型的系统评价
Epidemiol Rev. 2025 Jan 10;47(1). doi: 10.1093/epirev/mxaf009.
2
Health Inequities in the Epidemiology, Diagnosis, Treatment, and Outcomes of Plastic Surgery: A Scoping Review.整形外科学流行病学、诊断、治疗及结果中的健康不平等:一项范围综述
Plast Surg (Oakv). 2025 May;33(2):338-347. doi: 10.1177/22925503231210878. Epub 2023 Nov 3.
3
Socioeconomic Status and Breast Cancer Treatment in the United States: Results From a Systematic Literature Review.

本文引用的文献

1
Multidisciplinary care of breast cancer patients: a scoping review of multidisciplinary styles, processes, and outcomes.乳腺癌患者的多学科护理:多学科模式、流程和结果的范围综述。
Curr Oncol. 2019 Jun;26(3):e385-e397. doi: 10.3747/co.26.4713. Epub 2019 Jun 1.
2
Treatment delays from transfers of care and their impact on breast cancer quality measures.治疗延误与转移护理及其对乳腺癌质量指标的影响。
Breast Cancer Res Treat. 2019 Feb;173(3):603-617. doi: 10.1007/s10549-018-5046-x. Epub 2018 Nov 15.
3
Changing local therapy in breast cancer: who needs what, and when?
美国的社会经济地位与乳腺癌治疗:系统文献综述结果
Cancer Control. 2025 Jan-Dec;32:10732748251341520. doi: 10.1177/10732748251341520. Epub 2025 May 9.
4
Disparities in Breast Cancer Care-How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity.乳腺癌治疗的差异——与预防、诊断和治疗相关的因素如何导致不平等。
Healthcare (Basel). 2024 Feb 12;12(4):462. doi: 10.3390/healthcare12040462.
5
Prescription patterns of granulocyte colony-stimulating factors in patients with breast cancer: A real-world study.乳腺癌患者粒细胞集落刺激因子的处方模式:一项真实世界研究。
PLoS One. 2023 Jul 17;18(7):e0288642. doi: 10.1371/journal.pone.0288642. eCollection 2023.
6
Delays in Initiating Anti-Cancer Therapy for Early-Stage Breast Cancer-How Slow Can We Go?早期乳腺癌启动抗癌治疗的延迟——我们能有多慢?
J Clin Med. 2023 Jul 5;12(13):4502. doi: 10.3390/jcm12134502.
7
Rural-Urban Differences in Breast Cancer Surgical Delays in Medicare Beneficiaries.农村-城市间医疗保险受益人群乳腺癌手术延迟的差异
Ann Surg Oncol. 2022 Sep;29(9):5759-5769. doi: 10.1245/s10434-022-11834-4. Epub 2022 May 24.
乳腺癌局部治疗的改变:谁需要什么治疗,何时需要?
Clin Adv Hematol Oncol. 2018 Sep;16(9):609-618.
4
The implications of insurance status on presentation, surgical management, and mortality among nonmetastatic breast cancer patients in Indiana.印第安纳州非转移性乳腺癌患者的保险状况对其就诊、手术治疗和死亡率的影响。
Surgery. 2018 Dec;164(6):1366-1371. doi: 10.1016/j.surg.2018.07.012. Epub 2018 Aug 28.
5
Timing and Delays in Breast Cancer Evaluation and Treatment.乳腺癌评估和治疗中的时间和延误。
Ann Surg Oncol. 2018 Oct;25(10):2829-2838. doi: 10.1245/s10434-018-6615-2. Epub 2018 Jul 2.
6
Risk-reducing mastectomy for the prevention of primary breast cancer.预防性乳房切除术以预防原发性乳腺癌。
Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD002748. doi: 10.1002/14651858.CD002748.pub4.
7
Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy: A PRISMA-compliant systematic review and meta-analysis.新辅助化疗取得良好反应后,局部晚期乳腺癌保乳手术与乳房切除术的比较:一项遵循PRISMA标准的系统评价和荟萃分析
Medicine (Baltimore). 2017 Oct;96(43):e8367. doi: 10.1097/MD.0000000000008367.
8
Understanding Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early-Stage Breast Cancer.了解早期乳腺癌患者选择乳房切除术与保乳治疗的原因
Clin Med Insights Oncol. 2017 Feb 23;11:1179554917691266. doi: 10.1177/1179554917691266. eCollection 2017.
9
Time to Surgery and Breast Cancer Survival in the United States.美国的手术时间与乳腺癌生存
JAMA Oncol. 2016 Mar;2(3):330-9. doi: 10.1001/jamaoncol.2015.4508.
10
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.定制疗法——改善早期乳腺癌的管理:2015年早期乳腺癌初始治疗圣加仑国际专家共识
Ann Oncol. 2015 Aug;26(8):1533-46. doi: 10.1093/annonc/mdv221. Epub 2015 May 4.